Lenzing's High-Wire Act: Doubled Profits, Plant Closures, and a €300m Bet on the Future
Published on 08/12/2026 at 16:43 | Redaktion boerse-global.de
There is a moment in every corporate turnaround when strategy stops being a PowerPoint slide and starts costing real money. For Lenzing, that moment is now. The Austrian fibre maker has posted a first-half net result that more than doubled year-on-year, yet the numbers that matter most are the ones that will land on shareholders' desks on August 25 — when an extraordinary general meeting votes on a €300m rights issue wrapped inside a €600m refinancing package.
The juxtaposition is stark. On one hand, a bottom line that improved to €35.6m from €15.2m in the prior-year period. On the other, a restructuring so deep that it involves shuttering production lines, selling off entire plants, and cutting roughly 2,000 jobs worldwide. This is not a company tinkering at the margins; it is one performing surgery on itself.
The Arithmetic of Reinvention
Lenzing's revenue for the first half slipped to €1.27bn from €1.34bn, a decline the company attributes to lower fibre sales volumes and prices, plus softer pulp prices. Some of that was deliberate — management has been walking away from low-margin standard fibres. But the trade-off shows up elsewhere. EBITDA eased to €239.2m from €268.6m, with the corresponding margin contracting from 20.0% to 18.9%. The second quarter alone brought in €651.7m in revenue, though earnings per share remained negative at minus €0.10.
The one figure that offers genuine comfort is free cash flow of €45.8m, marginally ahead of the €43.1m posted a year earlier. In a phase where liquidity is the difference between survival and capitulation, cash generation matters more than accounting profit.
When you're managing a business through a period of significant change, the last thing you need is to discover gaps in your workplace safety documentation. A free Risk Assessment Toolkit with 41 ready-to-use templates and checklists can help you document hazards properly and keep your operations running smoothly. Download the free Risk Assessment Toolkit
A Strategy With a Body Count
The strategic blueprint, unveiled on July 27, carries the slogan "Grow Nonwovens, Reset Textiles" — and the reset half is brutally literal. Lenzing will wind down fibre production at its Heiligenkreuz site in Austria by the end of 2026 and at Grimsby in the UK by the end of 2027. Both facilities are being put up for sale. The human toll is significant: 285 employees in Heiligenkreuz, 215 in Grimsby, and 600 administrative roles already flagged for elimination as part of a global reduction of around 2,000 positions by end-2027.
The financial cost of this retreat is equally substantial. Impairment charges for 2026 could reach €150m, with restructuring provisions of up to €40m on top. Burgenland's governor, Hans Peter Doskozil, has already offered political support and hasn't ruled out the province stepping in as a buyer — a measure of how seriously the local fallout is being taken.
The logic behind the portfolio shift is clear enough. Textile fibres currently account for 45% of Lenzing's business, but that share is slated to fall to roughly 30% over the medium term. Nonwovens and pulp are each expected to grow to around 30%, reflecting a pivot toward hygiene products, wet wipes, and filtration — markets where margins are more resilient than in the oversupplied standard textile segment. A parallel "performance programme" targets €120m in annual savings by end-2027 against the 2025 cost base.
New Leadership, Familiar Questions
The man steering this transformation is Georg Kasperkovitz, who took over as chief executive in early June alongside CFO Mathias Breuer and CPO/CTO Christian Skilich. The management team may be fresh, but the existential question is not: how does a European pulp fibre producer survive in a market defined by Chinese overcapacity? The answer being offered now is withdrawal from the attritional volume game and concentration on niches where pricing power can be defended.
Deutsche Bank responded to the results on August 6 by lifting its price target from €21.00 to €22.00 while keeping a "Hold" rating — a nod to improving numbers without endorsing the risk profile. Automated rating systems are less generous; one prominent analysis portal currently assigns the stock a "D-rating," a technical signal that captures near-term sentiment but says nothing about the strategic overhaul.
The Shareholder Test
The share price has been drifting around €23.05–€23.40, roughly 21–22.5% below the 52-week high of €29.75 reached in June, yet about 21% above the year's low of €19.40. That wide band tells its own story: the market hasn't decided whether the restructuring outweighs the dilution.
The August 25 vote is the fulcrum. The €300m rights issue, supported by a €600m overall package including new credit facilities, has already secured commitments from anchor shareholders B&C Group, Suzano, and Oberbank. That backing is meaningful — without it, the equity story would be considerably more precarious.
Restructuring brings change, and change brings new risks to how you manage your operations. Over 37,000 UK businesses already rely on a free Health & Safety Toolkit to stay compliant with regulations like COSHH and PUWER during periods of transition. Get the free Health & Safety Toolkit
Monthly performance shows the stock down roughly 5%, and over the past year it has shed more than 13%. Those numbers capture the gap between operational inflection and investor conviction. The refinancing decision will determine whether that gap begins to close, or whether the market's patience runs out before the transformation does. For long-term holders, the promise of a leaner, more profitable Lenzing is the prize. For those seeking a quick recovery, the next few weeks are likely to disappoint.
